These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7707319)

  • 41. Kinetic mechanism of reduction of testosterone by hepatic 5 beta-reductase of chicken and inhibition of the reductase activity by a secosteroid, an azasteroid and glycyrrhetinic acid.
    Yoshida M; Kuroki Y; Kobayashi E; Tamaoki B
    J Steroid Biochem Mol Biol; 1992 Jan; 41(1):29-36. PubMed ID: 1734934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic antiandrogenic effects of topical combinations of 5 alpha-reductase and androgen receptor inhibitors in the hamster sebaceous glands.
    Matias JR; Malloy VL; Orentreich N
    J Invest Dermatol; 1988 Nov; 91(5):429-33. PubMed ID: 3171218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C; Hollander C; Miller B
    Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat.
    Swinney DC
    Drug Metab Dispos; 1990; 18(6):859-65. PubMed ID: 1981529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
    Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A
    Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for distinct dehydrogenase and isomerase sites within a single 3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase protein.
    Luu-The V; Takahashi M; de Launoit Y; Dumont M; Lachance Y; Labrie F
    Biochemistry; 1991 Sep; 30(36):8861-5. PubMed ID: 1832298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapy.
    Geldof AA; Meulenbroek MF; Dijkstra I; Bohlken S; Rao BR
    J Cancer Res Clin Oncol; 1992; 118(1):50-5. PubMed ID: 1729259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a new type of specific competitive inhibitor of testosterone 5 alpha-reductase, in volunteers.
    Ohtawa M; Morikawa H; Shimazaki J
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):15-21. PubMed ID: 1657611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and optimization of a new family of type 3 17 beta-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry.
    Maltais R; Luu-The V; Poirier D
    J Med Chem; 2002 Jan; 45(3):640-53. PubMed ID: 11806715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of 4MA, a potent inhibitor of 5 alpha-reductase, on the growth of androgen-responsive human genitourinary tumors grown in athymic nude mice.
    Andriole GL; Rittmaster RS; Loriaux DL; Kish ML; Linehan WM
    Prostate; 1987; 10(3):189-97. PubMed ID: 3588410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and characterization by 1H and 13C nuclear magnetic resonance spectroscopy of 17 alpha-cyano, 17 alpha-aminomethyl, and 17 alpha-alkylamidomethyl derivatives of 5 alpha-dihydrotestosterone and testosterone.
    Mappus E; Chambon C; Rolland de Ravel M; Grenot C; Cuilleron CY
    Steroids; 1997; 62(8-9):603-20. PubMed ID: 9292935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative study on cytogenetic damage induced by homo-aza-steroidal esters in human lymphocytes.
    Mourelatos D; Papageorgiou A; Boutis L; Catsoulacos P
    Mutat Res; 1995 Feb; 334(1):19-22. PubMed ID: 7528334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.
    Délos S; Iehlé C; Martin PM; Raynaud JP
    J Steroid Biochem Mol Biol; 1994 Mar; 48(4):347-52. PubMed ID: 8142312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds.
    Nnane IP; Kato K; Liu Y; Long BJ; Lu Q; Wang X; Ling YZ; Brodie A
    Endocrinology; 1999 Jun; 140(6):2891-7. PubMed ID: 10342882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
    Zoppi S; Cocconi M; Natali A; Costantini A; Serio M; Martini L; Motta M
    J Clin Endocrinol Metab; 1986 Jul; 63(1):269-71. PubMed ID: 2423549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of testosterone metabolism in the brain and cloacal gland of the quail by specific inhibitors and antihormones.
    Alexandre C; Balthazart J
    J Endocrinol; 1987 Feb; 112(2):189-95. PubMed ID: 2950196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of 5alpha-reductase gene expression in stroma and epithelium of human prostate.
    Bruchovsky N; Sadar MD; Akakura K; Goldenberg SL; Matsuoka K; Rennie PS
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):397-404. PubMed ID: 9010345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective induction of apoptosis in the hamster flank sebaceous gland organ by a topical liposome 5-alpha-reductase inhibitor: a treatment strategy for acne.
    Li L; Tang L; Baranov E; Yang M; Amoh Y; Katsuoka K; Hoffman RM
    J Dermatol; 2010 Feb; 37(2):156-62. PubMed ID: 20175850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative studies of 5 alpha-reductase inhibitors within MCF-7 human breast cancer cells.
    MacIndoe JH; West ER; Petrow V
    J Steroid Biochem; 1984 May; 20(5):1095-100. PubMed ID: 6727360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.